Edwards Lifesciences' Chair Michael Mussallem is retiring from the board of directors a year after stepping down as CEO.
GE HealthCare (Nasdaq: GEHC) announced today that it launched its Prostate Volume Assist (PVA) urology-based AI software ...
Reuters reports that U.S. Rep. Earl Blumenauer (D-OR) wrote a letter to the FDA questioning inspection practices related to ...
SyntheticMR announced today that its next-generation 3D imaging solution with isotropic resolution received FDA 510(k) ...
In a rare move, the FDA is taking steps to ban electrical stimulation devices (ESDs) for self-injurious or aggressive ...
Synaptive Medical received FDA 510(k) clearance for its near-infrared fluoresence visualization model on its robotic exoscope ...
Medtronic (NYSE: MDT) announced that the FDA approved its next-generation Evolut FX+ transcatheter aortic valve replacement ...
Calyxo announced today that it received FDA clearance for its new, redesigned CVAC system for minimally invasive kidney stone ...
PathKeeper Surgical has entered into a know-how agreement with the Mayo Clinic to research radiation levels in pediatric ...
Stryker (NYSE: SYK)announced today that it launched its Gamma4 hip fracture nailing system across most European markets.
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it initiated a limited commercial launch for its OneRF ...
Johnson & Johnson MedTech's Biosense Webster announced today that it submitted its Varipulse platform to the FDA for ...